Krithika Subramanian, PhD


Targeting the NF-κB Pathway in Duchenne Muscular Dystrophy

December 24, 2019

An in-depth analysis of the genetics of DMD and disease modifiers such as the NF-kB pathway in patients with Duchenne muscular dystrophy.

Exploring the Role of B Cells and CD20 in Multiple Sclerosis

November 28, 2019

Although there are no cures for MS at present, the treatment landscape has changed significantly, with over a dozen approved disease-modifying therapies (DMTs) representing multiple classes of agents with different mechanisms of action.

CGRP: Paving the Path to Migraine and Its Treatment

September 30, 2019

After a long period of time with minimally effective treatments for migraine, the growing understanding of the CGRP pathway has opened the door to a variety of new and highly efficacious therapies for patients with chronic and episodic forms of disease.